MT Daniel

9.2k total citations · 4 hit papers
42 papers, 7.2k citations indexed

About

MT Daniel is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, MT Daniel has authored 42 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 18 papers in Molecular Biology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in MT Daniel's work include Acute Myeloid Leukemia Research (24 papers), Retinoids in leukemia and cellular processes (14 papers) and Acute Lymphoblastic Leukemia research (12 papers). MT Daniel is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Retinoids in leukemia and cellular processes (14 papers) and Acute Lymphoblastic Leukemia research (12 papers). MT Daniel collaborates with scholars based in France, United States and Belgium. MT Daniel's co-authors include Georges Flandrin, H. R. Gralnick, John M. Bennett, C. Sultan, Daniel Catovsky, D. A. G. Galton, Christine Chomienne, Sylvie Castaigné, Pierre Fenaux and Paola Ballerini and has published in prestigious journals such as Blood, Cancer and British Journal of Haematology.

In The Last Decade

MT Daniel

40 papers receiving 6.9k citations

Hit Papers

Proposals for the classification of the myelodysplastic s... 1981 2026 1996 2011 1982 1990 1989 1981 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MT Daniel France 22 5.3k 2.9k 1.9k 1.4k 1.2k 42 7.2k
A Hagemeijer Netherlands 45 3.2k 0.6× 2.1k 0.7× 1.5k 0.8× 1.5k 1.0× 580 0.5× 135 5.9k
Rosemary E. Gale United Kingdom 44 5.2k 1.0× 3.2k 1.1× 2.3k 1.2× 1.4k 1.0× 810 0.7× 115 7.4k
JD Rowley United States 40 3.8k 0.7× 2.2k 0.7× 1.2k 0.6× 1.6k 1.1× 378 0.3× 78 5.1k
Luc Douay France 35 1.9k 0.4× 1.4k 0.5× 1.1k 0.6× 538 0.4× 612 0.5× 143 4.4k
Paola Ballerini France 31 2.1k 0.4× 2.5k 0.8× 627 0.3× 1.1k 0.8× 564 0.5× 78 4.6k
AC Eaves Canada 39 4.2k 0.8× 1.6k 0.5× 2.1k 1.1× 413 0.3× 1.3k 1.1× 83 6.0k
Jean‐Luc Villeval France 43 4.9k 0.9× 3.2k 1.1× 4.4k 2.3× 357 0.2× 929 0.8× 125 7.9k
Thierry Lamy France 41 1.9k 0.4× 1.4k 0.5× 2.1k 1.1× 397 0.3× 2.6k 2.2× 177 6.4k
Chor Sang Chim China 40 2.3k 0.4× 3.3k 1.1× 866 0.4× 322 0.2× 1.1k 0.9× 240 6.8k
Chihiro Shimazaki Japan 33 2.4k 0.4× 1.5k 0.5× 813 0.4× 465 0.3× 659 0.6× 213 4.0k

Countries citing papers authored by MT Daniel

Since Specialization
Citations

This map shows the geographic impact of MT Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MT Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MT Daniel more than expected).

Fields of papers citing papers by MT Daniel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MT Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MT Daniel. The network helps show where MT Daniel may publish in the future.

Co-authorship network of co-authors of MT Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of MT Daniel. A scholar is included among the top collaborators of MT Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MT Daniel. MT Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malphettes, Marion, et al.. (2019). La synartèse : une cause rare d’anémie, à traiter en ciblant le pic. La Revue de Médecine Interne. 40. A125–A126.
2.
Kelaïdi, Charikleia, Sophie Park, Sabine Bréchignac, et al.. (2008). Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide. Leukemia Research. 32(7). 1049–1053. 59 indexed citations
3.
Vignes, S., Éric Oksenhendler, Laurent Quint, et al.. (2000). Hyperlymphocytose B polyclonale et hyper-IgM : déficit immunitaire et/ou prolifération lymphoïde bénigne associé(s) au tabac ?. La Revue de Médecine Interne. 21(3). 236–241. 2 indexed citations
4.
Bastié, Jean, Dominique Cazals‐Hatem, MT Daniel, et al.. (1999). Five Years Follow-Up after 2-Chloro Deoxyadenosine Treatment in Thirty Patients with Hairy Cell Leukemia: Evaluation of Minimal Residual Disease and CD4+ Lymphocytopenia after Treatment. Leukemia & lymphoma. 35(5-6). 555–565. 39 indexed citations
5.
Berger, Roland, Maryvonne Le Coniat, MT Daniel, et al.. (1997). Chromosome abnormalities of the short arm of chromosome 12 in hematopoietic malignancies: a report including three novel translocations involving the TEL/ETV6 gene. Leukemia. 11(9). 1400–1403. 19 indexed citations
6.
Cayuela, JM, André Baruchel, A Madani, et al.. (1996). TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood. 88(1). 302–308. 8 indexed citations
7.
Madani, A, Jean Soulier, Valère Cacheux, et al.. (1996). Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations. Blood. 87(5). 1923–1927. 3 indexed citations
8.
Jonveaux, Philippe, et al.. (1996). Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma.. PubMed. 10(9). 1453–5. 64 indexed citations
9.
Cayuela, JM, André Baruchel, A Madani, et al.. (1996). TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood. 88(1). 302–308. 62 indexed citations
10.
Daniel, MT, et al.. (1993). PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 82(6). 1858–1867. 21 indexed citations
11.
Daniel, MT, et al.. (1993). PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 82(6). 1858–1867. 204 indexed citations
12.
Degos, L, Sylvie Castaigné, Pierre Fenaux, MT Daniel, & Christine Chomienne. (1991). Le traitement des leucémies aiguës à promyélocytes par l'acide tout-trans rétinoïque.. médecine/sciences. 7(5). 460–460.
14.
Chomienne, Christine, Paola Ballerini, N Balitrand, et al.. (1990). All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood. 76(9). 1710–1717. 14 indexed citations
15.
Bennett, John M., D Catovsky, MT Daniel, et al.. (1989). Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.. Journal of Clinical Pathology. 42(6). 567–584. 565 indexed citations breakdown →
16.
Najean, Y, et al.. (1988). Acute leukemia and myelodysplasia in polycythemia vera.A clinical study with long-term follow-up. Cancer. 61(1). 89–95. 55 indexed citations
17.
Daniel, MT, et al.. (1983). Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?. Blood. 62(1). 85–86. 137 indexed citations
18.
Daniel, MT, et al.. (1983). Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?. Blood. 62(1). 85–86. 2 indexed citations
19.
Berger, R, Alain Bernheim, MT Daniel, F Valensi, & G Flandrin. (1981). Karyotype and cell phenotypes in primary acute leukemias.. PubMed. 7(2). 287–92. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026